Pharma Industry News Weekly Recap: March 24, 2023
// Biotech and Pharma Therapeutics Novo Nordisk, Eli Lilly replenish Type 2 diabetes stars Ozempic, Mounjaro after off-label [...]
// Biotech and Pharma Therapeutics Novo Nordisk, Eli Lilly replenish Type 2 diabetes stars Ozempic, Mounjaro after off-label [...]
// Biotech and Pharma Therapeutics Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US March [...]
// Biotech and Pharma Therapeutics With PCSK9 pill, Merck aims to succeed where others failed March 7, 2023 / [...]
// Biotech and Pharma Therapeutics After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year [...]
Jardiance Becomes First SGLT2 Inhibitor to Show Benefit in HFpEF July 7, 2021 Cardiovascular / Diabetes / Pharmaceuticals Eli [...]
Lilly, Novo Nordisk Present Promising Data in Type 2 Diabetes June 28, 2021 Diabetes / Pharmaceuticals Eli Lilly's investigational diabetes [...]
3D Printing Provides a Potential Cure for Diabetes June 22, 2021 Diabetes / Biotech / 4IR - 3D Printing Readily3D, [...]
60 days until the J.P. Morgan 38th annual Healthcare Conference (#JPM2020). Removing the upcoming holidays and weekends, we’re talking 36 [...]
Investors Hunt for Biotech Winners as Wider Stock Market Churns October 19, 2018 Biotech / FinanceSince hitting a 52-week [...]
Slowly, but ever so surely, the diabetes treatment landscape is evolving along two continuums. The first is the world of [...]